CRT Should Slow Heart Failure Progression, Not Merely Lift Symptoms – Panel
This article was originally published in The Gray Sheet
Executive Summary
Peak VO2 level is an impractical endpoint to use in clinical trials of cardiac resynchronization therapy (CRT) devices, panelists agreed at a recent Heart Failure Society of America event in Washington, D.C